Archive - April 2018
Patients Receive new Treatment Options from NAU Urology
HBA’s Woman of the Year 2018
Trading Big Pharma for Small Startup
HEOR Education: Evolving the Skill Set
Merck’s Keytruda scores in frontline lung cancer yet again
Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal
AbbVie’s upadacitinib aces phase III trial
Alkermes Receives Refusal to File Letter From FDA for ALKS 5461